loading
前日終値:
$317.09
開ける:
$318.42
24時間の取引高:
68,130
Relative Volume:
0.19
時価総額:
$6.92B
収益:
-
当期純損益:
$-518.67M
株価収益率:
-16.65
EPS:
-19.24
ネットキャッシュフロー:
$-438.32M
1週間 パフォーマンス:
+6.18%
1か月 パフォーマンス:
+53.84%
6か月 パフォーマンス:
+32.53%
1年 パフォーマンス:
+70.54%
1日の値動き範囲:
Value
$315.15
$322.48
1週間の範囲:
Value
$272.72
$323.99
52週間の値動き範囲:
Value
$168.25
$368.29

Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile

Name
名前
Madrigal Pharmaceuticals Inc
Name
セクター
Healthcare (1195)
Name
電話
404-380-9263
Name
住所
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA
Name
職員
376
Name
Twitter
@MadrigalPharma
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
MDGL's Discussions on Twitter

MDGL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
MDGL 320.87 6.92B 0 -518.67M -438.32M -19.24
VRTX 448.37 115.74B 10.63B -479.80M -1.35B 13.33
REGN 743.45 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 588.56 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.89 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.28 24.49B 3.30B -501.07M 1.03B 11.54

Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-12-20 繰り返されました Oppenheimer Outperform
2022-12-19 繰り返されました H.C. Wainwright Buy
2022-12-19 繰り返されました Piper Sandler Overweight
2022-12-19 アップグレード Raymond James Underperform → Mkt Perform
2022-07-08 ダウングレード B. Riley Securities Buy → Neutral
2021-10-07 開始されました Jefferies Buy
2021-08-06 アップグレード BMO Capital Markets Market Perform → Outperform
2021-05-20 再開されました Goldman Buy
2020-11-24 再開されました Evercore ISI Outperform
2020-11-06 繰り返されました H.C. Wainwright Buy
2020-07-31 開始されました Piper Sandler Overweight
2020-06-05 開始されました BMO Capital Markets Market Perform
2020-05-05 開始されました Chardan Capital Markets Buy
2020-01-30 開始されました Canaccord Genuity Buy
2020-01-09 アップグレード UBS Neutral → Buy
2019-11-07 繰り返されました H.C. Wainwright Buy
2019-06-25 開始されました Stifel Hold
2019-06-10 アップグレード B. Riley FBR Neutral → Buy
2019-02-28 繰り返されました H.C. Wainwright Buy
2019-02-22 開始されました SVB Leerink Outperform
2019-01-23 開始されました UBS Neutral
2018-12-14 開始されました Wolfe Research Outperform
2018-12-12 開始されました B. Riley FBR Neutral
2018-11-19 ダウングレード Raymond James Mkt Perform → Underperform
2018-11-16 アップグレード Evercore ISI In-line → Outperform
2018-09-04 開始されました Citigroup Buy
2018-08-06 ダウングレード Goldman Buy → Neutral
2018-06-28 開始されました Raymond James Mkt Perform
すべてを表示

Madrigal Pharmaceuticals Inc (MDGL) 最新ニュース

pulisher
06:12 AM

Connor Clark & Lunn Investment Management Ltd. Sells 10,979 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat

06:12 AM
pulisher
03:10 AM

Madrigal shares hold as Cowen maintains price target on new data - Investing.com Canada

03:10 AM
pulisher
Nov 20, 2024

Novo semaglutide data in MASH could negatively impact Madrigal's Rezdiffra (MDGL:NASDAQ) - Seeking Alpha

Nov 20, 2024
pulisher
Nov 20, 2024

Madrigal Pharmaceuticals Engages with Investors at Key Conferences - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Madrigal Pharmaceuticals (NASDAQ:MDGL) Given "Neutral" Rating at Cantor Fitzgerald - MarketBeat

Nov 20, 2024
pulisher
Nov 19, 2024

Novo Nordisk’s Semaglutide Tops Madrigal’s Rezdiffra In NASH - Scrip

Nov 19, 2024
pulisher
Nov 18, 2024

(11/18/24) MDGL: A Promising Play in the Weight Loss Drug Space - Moneyshow.com

Nov 18, 2024
pulisher
Nov 16, 2024

Madrigal Pharmaceuticals gains amid takeover speculation - MSN

Nov 16, 2024
pulisher
Nov 15, 2024

John Paulson's Strategic Acquisition in Madrigal Pharmaceuticals - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Janus Henderson Group PLC's Strategic Reduction in Madrigal Phar - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

RTW INVESTMENTS, LP Expands Stake in Madrigal Pharmaceuticals Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

(MDGL) Trading Report - Stock Traders Daily

Nov 13, 2024
pulisher
Nov 11, 2024

Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar And Theravance - Barchart

Nov 11, 2024
pulisher
Nov 11, 2024

Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance - Yahoo Finance

Nov 11, 2024
pulisher
Nov 10, 2024

1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More - AOL

Nov 10, 2024
pulisher
Nov 09, 2024

Fiera Capital Corp Sells 3,535 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

Madrigal Pharmaceuticals director Richard Levy sells $1.75 million in stock By Investing.com - Investing.com Canada

Nov 09, 2024
pulisher
Nov 09, 2024

Madrigal Pharmaceuticals director Richard Levy sells $1.75 million in stock - Investing.com India

Nov 09, 2024
pulisher
Nov 07, 2024

3 High Growth Tech Stocks Leading The US Market - Simply Wall St

Nov 07, 2024
pulisher
Nov 07, 2024

B. Riley Has Bullish Estimate for MDGL FY2024 Earnings - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Here's Why Madrigal (MDGL) is a Great Momentum Stock to Buy - Yahoo Finance

Nov 07, 2024
pulisher
Nov 06, 2024

Madrigal Pharmaceuticals (FRA:YDO1) Current Ratio : 5.98 (As of Sep. 2024) - GuruFocus.com

Nov 06, 2024
pulisher
Nov 06, 2024

Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Madrigal Pharmaceuticals to Present at Three Major Healthcare Investor Conferences | MDGL Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

Analysts Offer Predictions for MDGL Q1 Earnings - MarketBeat

Nov 06, 2024
pulisher
Nov 05, 2024

Madrigal Pharmaceuticals director Richard Levy sells $1.5m in shares - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

Madrigal Pharmaceuticals director Richard Levy sells $1.5m in shares By Investing.com - Investing.com UK

Nov 05, 2024
pulisher
Nov 05, 2024

Non-Alcoholic Steatohepatitis Market to Show Remarkable Growth Trends from 2023 to 2032, DelveInsight Reports | Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Viking Therapeutics, Madrigal - Barchart

Nov 05, 2024
pulisher
Nov 05, 2024

B. Riley Forecasts Strong Price Appreciation for Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

MDGL (Madrigal Pharmaceuticals) Change In Receivables : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

Check Out What Whales Are Doing With MDGL - Benzinga

Nov 04, 2024
pulisher
Nov 04, 2024

Madrigal Stock Soars 23% as NASH Drug Rezdiffra Crushes Expectat - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

Madrigal Pharmaceuticals (NASDAQ:MDGL) Reaches New 1-Year High After Analyst Upgrade - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Madrigal Stock Soars 23% as NASH Drug Rezdiffra Crushes Expectations - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

FY2028 Earnings Forecast for MDGL Issued By Leerink Partnrs - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Emerald Advisers LLC Has $5.79 Million Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio? - Benzinga

Nov 03, 2024
pulisher
Nov 03, 2024

Rezdiffra Gains Traction In NASH As Madrigal Pharmaceuticals Targets European Expansion - Seeking Alpha

Nov 03, 2024
pulisher
Nov 02, 2024

(MDGL) Long Term Investment Analysis - Stock Traders Daily

Nov 02, 2024
pulisher
Nov 02, 2024

Madrigal, 89Bio jump after Novo’s semaglutide shows promise in MASH - Yahoo Finance

Nov 02, 2024
pulisher
Nov 02, 2024

Forecast: Analysts Think Madrigal Pharmaceuticals, Inc.'s (NASDAQ:MDGL) Business Prospects Have Improved Drastically - Simply Wall St

Nov 02, 2024
pulisher
Nov 02, 2024

Analysts Just Made A Notable Upgrade To Their Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Forecasts - Yahoo Finance

Nov 02, 2024
pulisher
Nov 02, 2024

Madrigal Q3 Earnings Beat, NASH Drug Sales Drive Top Line, Stock Up - MSN

Nov 02, 2024
pulisher
Nov 02, 2024

Madrigal Pharmaceuticals Announces Strong Q3 2024 Results and Strategic Advances - MSN

Nov 02, 2024
pulisher
Nov 01, 2024

MDGL stock soars to 52-week high, reaching $299.99 By Investing.com - Investing.com South Africa

Nov 01, 2024
pulisher
Nov 01, 2024

Madrigal Pharma Stock Soars Despite Novo Nordisk’s ‘Superior’ MASH Trial Results: Retail Bullish On Earnings Beat - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

Novo's Wegovy Isn't A 'Silver Bullet' For MASH. Madrigal Rockets. - Investor's Business Daily

Nov 01, 2024
pulisher
Nov 01, 2024

Madrigal Pharmaceuticals stock jumps on MASH drug hopes - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Raised to $441.00 - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Madrigal Pharmaceuticals (NASDAQ:MDGL) Releases Earnings Results, Beats Expectations By $2.02 EPS - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

MDGL stock soars to 52-week high, reaching $299.99 - Investing.com

Nov 01, 2024

Madrigal Pharmaceuticals Inc (MDGL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):